Symposia: Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Hodgkin lymphoma, Adult, Acute Myeloid Malignancies, AML, MDS, Lymphomas, Clinical Practice (Health Services and Quality), Elderly, Translational Research, Clinical Research, Plasma Cell Disorders, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chronic Myeloid Malignancies, Diseases, Treatment Considerations, Biological therapies, Immunotherapy, Lymphoid Malignancies, Young adult , Myeloid Malignancies, Miscellaneous Cellular Therapies, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous)
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Hodgkin lymphoma, Adult, Acute Myeloid Malignancies, AML, MDS, Lymphomas, Clinical Practice (Health Services and Quality), Elderly, Translational Research, Clinical Research, Plasma Cell Disorders, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chronic Myeloid Malignancies, Diseases, Treatment Considerations, Biological therapies, Immunotherapy, Lymphoid Malignancies, Young adult , Myeloid Malignancies, Miscellaneous Cellular Therapies, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous)
Monday, December 9, 2024: 2:45 PM-4:15 PM
Hall B
(San Diego Convention Center)
Moderators:
Lekha Mikkilineni, MD, MA,
and
Natalie Grover, MD, NULL
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH